Breathable liquid elimination analysis

Surgery – Truss – Pad

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

128716, 128719, 12820014, 12820312, 12820418, 128913, A61B 5097, A61M 1600

Patent

active

055906516

ABSTRACT:
The amount of breathable liquid eliminated from a mammal through volatilization in the lungs and/or through skin transpiration is detected by measuring the amount of saturation of the expiratory gas by vapors or the breathable liquid. Instantaneous saturation values are employed to gauge the amount of interaction in the lungs between the breathable liquid and respiratory gas flowing therein and to control selected feedback operations to maintain the maximum possible amount of interaction therebetween. The saturation level of expiratory gas is also employed to optimize operating parameters or a system for recovering the breathable liquid from the expiratory gas, directly from the patient, or from a gas or liquid ventilator. The saturation level or expiratory gas is also employed to perform functional residual capacity studies and to correct for errors in conventional functional residual capacity measurements performed while a patient undergoes partial liquid ventilation. When breathable liquid is employed as a blood substitute, the quantification or the loss of the breathable liquid from volatilization and transpiration helps to determine when to replenish the breathable liquid in the bloodstream. Vapors of one form of breathable liquid, perfluorocarbon, are employed to determine the functional residual capacity of a mammal's lung.

REFERENCES:
patent: 3682166 (1972-08-01), Jacobs
patent: 3794026 (1974-02-01), Jacobs
patent: 3895630 (1975-07-01), Bachman
patent: 3901230 (1975-08-01), Henkin
patent: 3983864 (1976-10-01), Sielaff et al.
patent: 4230126 (1980-10-01), Elings
patent: 4232665 (1980-11-01), Vaseen
patent: 4233842 (1980-11-01), Raemer et al.
patent: 4252827 (1981-02-01), Yokoyama et al.
patent: 4378797 (1983-04-01), Osterholm
patent: 4444498 (1984-04-01), Heinemann
patent: 4451251 (1984-05-01), Osterholm
patent: 4470298 (1984-09-01), Jibelian
patent: 4490351 (1984-12-01), Clark, Jr.
patent: 4493692 (1985-01-01), Reed
patent: 4538605 (1985-09-01), Gedeon et al.
patent: 4586500 (1986-05-01), Glynn
patent: 4586511 (1986-05-01), Clark, Jr.
patent: 4657532 (1987-04-01), Osterholm
patent: 4661092 (1987-04-01), Popovich et al.
patent: 4676774 (1987-06-01), Semm et al.
patent: 4721677 (1988-01-01), Clark, Jr.
patent: 4775522 (1988-10-01), Clark, Jr.
patent: 4781676 (1988-11-01), Schweighardt et al.
patent: 4795423 (1989-01-01), Osterholm
patent: 4850371 (1989-07-01), Broadhurst et al.
patent: 4865836 (1989-09-01), Long, Jr.
patent: 4891629 (1990-01-01), Gajjar, et al.
patent: 4919895 (1990-04-01), Heldebrant et al.
patent: 4928687 (1990-05-01), Lampotang et al.
patent: 4960568 (1990-10-01), Matsumoto et al.
patent: 4963130 (1990-10-01), Osterholm
patent: 4966578 (1990-10-01), Baier et al.
patent: 4993415 (1991-02-01), Long
patent: 4994158 (1991-02-01), Kiimalainen et al.
patent: 5038792 (1991-08-01), Mault
patent: 5047010 (1991-09-01), Ams et al.
patent: 5072726 (1991-12-01), Mazloomdoost et al.
patent: 5072737 (1991-12-01), Goulding
patent: 5080645 (1992-01-01), Hanig
patent: 5084011 (1992-01-01), Grady
patent: 5111827 (1992-05-01), Rantala
patent: 5137510 (1992-08-01), VanDeripe
patent: 5149319 (1992-09-01), Unger
patent: 5149321 (1992-09-01), Klatz et al.
patent: 5158536 (1992-10-01), Sekins, et al.
patent: 5178155 (1993-01-01), Mault
patent: 5200430 (1993-04-01), Federman
patent: 5207220 (1993-05-01), Long
patent: 5213570 (1993-05-01), VanDeripe
patent: 5234405 (1993-08-01), Klatz et al.
patent: 5244924 (1993-09-01), Meinert
patent: 5277176 (1994-01-01), Habashi et al.
patent: 5279288 (1994-01-01), Christopher
patent: 5291879 (1994-03-01), Babb et al.
patent: 5309903 (1994-05-01), Long
patent: 5335650 (1994-08-01), Shaffer et al.
patent: 5437272 (1995-08-01), Fuhrman
Perry's Chemical Engineers' Handbook, Sixth Edition, McGraw Hill Book Co., ew York, 1984, pp. 3-247, 3-254, 3-255, 3-282 through 285, 22-48 and 22-49.
McGraw-Hill Encyclopedia of Science & Technology, 6th Edition, 1987, vol. 5, pp. 222-223.
Breuninger, H., Rubenstein, S.C., Wolfson, M. R., Shaffer, T. H. Effect of exchange transfusion with a red blood cell substitute on neonatal hemodynamics and organ blood flows. J. Pediatr Surg. 28 (2), 144-150, 1993.
Thomas, S. R., Clark, L. C., Acerman, J. L. MR imaging of the lung using liquid perfluorocarbons. J Comput Assist Tomogr 10: 529-537, 1986.
Avery, M. E. & Mead, J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child; 97; 517-523, 1959.
Brumley, G. W., Chernick, V., Hodson, A. H., Normand, C., Fenner, A., Avery, M. E. Correlations of mechanical stability, morphology, pulmonary surfactant, and phospholipid content in the developing lamb lung. J. Clin Invest; 46(5); 863-873, 1987.
Collaboration European Multicenter Study Group. Surfactant replacement therapy for severe neonatal distress syndrome: an international randomized trial. Pediatrics 82: 683-691, 1988.
Jobe, A. H., Ikkegami, M. Surfactant for treatment of respiratory distress syndrome. Am Rev Respir Dis 136: 1256-1275, 1987.
Calderwood, H. W., Ruiz, B. C., Tham, M. K., Modell, J. H., Hood C. I. Residual levels and biochemical changes after ventilation with perfluorinated liquid. J. Appl Physiol 139: 603-607, 1975.
Curtis, S. E., Fuhrman, B. P., Howland, D. F. Airway and alveolar pressures during perfluorocarbon breathing in infant lambs. J. Appl Physio 68(6): 2322-2328, 1990.
Koen, P. A., Wolfson, M. R., Shaffer, T. H. Fluorocarbon ventilation: maximal expiratory flows and CO.sub.2 elimination. Pediatr Res 24: 291-296, 1988.
Modell, J. H., Gollan, F., Giammona, S. T., Parker, D. Effect of fluorocarbon liquid on surface tension properties of pulmonary surfactant. Chest 57: 263-265, 1970.
Sargent, J. S., Seffl, R. J. Properties of perfluoronated liquid. Fed Proc Fed Am Soc Exp Biol 29: 1699-1703, 1970.
Schweiler, G. H., Robertson, B. Liquid ventilation in immature newborn rabbits. Biol Neonate 29: 343-353, 1976.
Shaffer, T. H., Tran, N., Bhutani, V. K., Sivieri, E. M. Cardiopulmonary function in very pre-term lambs during liquid ventilation. Pediatr Res 17: 680-684, 1983.
Shaffer, T. H., Lowe, C. A., Bhutani, V. K., Douglas, P. R. Liquid ventilation: effects on pulmonary function in distressed, meconium-stained lambs. Pediatr Res 18: 47-52, 1984.
Shaffer, T. H., A brief review: Liquid ventilation. Undersea Biomed Res 14: 169-179, 1987.
Wolfson, M. R., Tran, N., Bhutani, V. K., Shaffer, T. H. A new experimental approach for the study of cardiopulmonary physiology during early development. J. Appl Physiol 65: 1436-1443, 1988.
Holaday, D. A., Fiserova-Bergerova, V. J. H., Modell, H. W. Uptake, distribution, and excretion of fluorocarbon FX-80 during liquid breathing in the dog. Anesthesiology 37: 387-394, 1972.
Model, J., Tham, M. K., Modell, J. H., Calderwood, B. C. Ruiz. Distribution and retention of fluorocarbon in mice and dogs after injection or liquid ventilation. Toxicol Appl Pharmacol 26: 86-92, 1973.
Greenspan, J. S., Wolfson, M. R., Rubenstein, S. D., Shaffer, T. H. Liquid ventilation of human preterm neonates. J of Ped 117: 106-111, 1990.
Wolfson, M. R. Pulmonary administration of drug (PAD): a new approach for drug delivery using liquid ventilation. Faseb Journal 4(4): A1105, 1990.
Wolfson, M. R., Greenspan, J. S., Shaffer, T. H. Pulmonary administration of vasoactive drugs (PAD) by perfluorocarbon liquid ventilation. Pediatr Res 29(4): 336A, 1991.
Greenspan, J. S., Wolfson, M. R., Rubenstein, S. D., Shaffer, T. H. Liquid ventilation of human preterm neonates. J of Ped 117: 106-111, 1990.
Wolfson, M. R. Pulmonary administration of drug (PAD): a new approach for drug delivery using liquid ventilation. Faseb Journal 4(4): A1105, 1990 (Abstract 1989).
Wolfson, M. R., Greenspan, J. S., Shaffer, T. H. Pulmonary administration of vasoactive drugs (PAD) by perfluorocarbon liquid ventilation. Pediatr Res 29(4): 336A, 1991 (Abstract 1991).
Greenspan, J. S., Wolfson, M. R., Rubenstein, S. D., Shaffer, T. H. Liquid ventilation of human preterm neonates. J of Ped 117: 106-111, 1990 (Abstract 1991).
Wolfson, M. R. Pulmonary administration of drug (PAD): a new approach for

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Breathable liquid elimination analysis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Breathable liquid elimination analysis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Breathable liquid elimination analysis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1757298

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.